U.S. Markets close in 3 hrs 2 mins

Gilead Sciences, Inc. (GILD)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
70.42-1.50 (-2.09%)
As of 12:57PM EDT. Market open.
People also watch
CELGBIIBAMGNBMYREGN
Full screen
Previous Close71.92
Open72.00
Bid70.71 x 100
Ask70.72 x 500
Day's Range70.37 - 72.17
52 Week Range63.76 - 88.85
Volume5,215,338
Avg. Volume8,580,523
Market Cap92.02B
Beta0.97
PE Ratio (TTM)7.44
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.08 (2.94%)
Ex-Dividend Date2017-06-14
1y Target EstN/A
Trade prices are not sourced from all markets
  • InvestorPlace4 hours ago

    Trade of the Day: Gilead Sciences, Inc. (GILD)

    Gilead Sciences, Inc. (NASDAQ:GILD) started climbing higher last week in anticipation of the announcement of the Senate Republicans’ health care bill, in which traders believed they would find good news for biopharmaceutical firms like GILD. This uptrend stalled briefly as a few Senate Republicans have balked at backing the bill, forcing a delay of a vote on the bill until after the July 4 recess, but we believe that consolidation is over.

  • Investopediayesterday

    Why Gilead Is Still a Value Trap

    Gilead Sciences remains a value trap because it's still not doing anything with its cash.

  • Healthcare Guru Samuel Isaly Plays Two Key Biotech Stocks: Synergy Pharmaceuticals Inc (SGPY), Gilead Sciences, Inc. (GILD)
    SmarterAnalyst2 days ago

    Healthcare Guru Samuel Isaly Plays Two Key Biotech Stocks: Synergy Pharmaceuticals Inc (SGPY), Gilead Sciences, Inc. (GILD)

    Sameul Isaly, founder of one of the world’s most well-known healthcare funds, has made two key moves on Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Gilead Sciences Inc (NASDAQ:GILD). Isaly is the managing partner of OrbiMed, a global management firm that has assets under management of over $13 billion. Isaly is closely tracked by investors due to his exceptional track record: at the beginning of 2016, Barron’s said he was the only US mutual fund manager to beat the S&P 500 for an incredible 25 straight years.